Protara Therapeutics (TARA) Capital Expenditures (2013 - 2025)
Protara Therapeutics (TARA) posted Capital Expenditures of $24,000 for Q4 2025, up 500.0% from the prior quarter.
Powered by 
Analysis
Protara Therapeutics (TARA) Capital Expenditures (2013 - 2025) Analysis & Trends
For FY2025, Protara Therapeutics' Capital Expenditures came in at $94,000, up 49.2% from FY2024.
- Annual Capital Expenditures shows a five-year compound annual growth rate of -36.1% (FY2020 to FY2025).
- In prior years, Protara Therapeutics' Capital Expenditures was $63,000 in FY2024 (+40.0%), $45,000 in FY2023 (-62.5%), $120,000 in FY2022 (-79.9%) and $596,000 in FY2021 (-32.6%).
- Quarterly Capital Expenditures has run from a low of -$64,000 in Q3 2021 to a high of $326,000 in Q2 2021 over five years.
- The strongest year-over-year quarter for Capital Expenditures in the past five years was Q1 2021, with growth of 17.4%; the weakest was Q1 2022, with a decline of 96.2%.
- According to Business Quant data, Capital Expenditures for the three prior quarters was $4,000 (Q3 2025), $22,000 (Q2 2025) and $44,000 (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 1.32 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 322.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 893.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -321.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -763.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 513.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 140.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 533.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 112.20 Mn |
| 10 | Protara Therapeutics | 180.21 Mn | 180.21 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 24,000.00 |
| Sep 30, 2025 | 4,000.00 |
| Jun 30, 2025 | 22,000.00 |
| Mar 31, 2025 | 44,000.00 |
| Sep 30, 2024 | 8,000.00 |
| Sep 30, 2023 | 37,000.00 |
| Jun 30, 2023 | 2,000.00 |
| Mar 31, 2023 | 6,000.00 |
| Dec 31, 2022 | 6,000.00 |
| Sep 30, 2022 | 83,000.00 |
| Jun 30, 2022 | 20,000.00 |
| Mar 31, 2022 | 11,000.00 |
| Dec 31, 2021 | 44,000.00 |
| Sep 30, 2021 | -64,000.00 |
| Jun 30, 2021 | 326,000.00 |
| Mar 31, 2021 | 290,000.00 |
| Dec 31, 2020 | 511,000.00 |
| Sep 30, 2020 | 132,000.00 |
| Jun 30, 2020 | -6,000.00 |
| Mar 31, 2020 | 247,000.00 |
API Access
Protara Therapeutics Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=TARA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "TARA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=TARA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();